Experimental and clinical pharmacology of pentosan polysulfate.
Maffrand
J P
JP
Sanofi Recherche, Toulouse, France.
Herbert
J M
JM
Bernat
A
A
Defreyn
G
G
Delebassee
D
D
Savi
P
P
Pinot
J J
JJ
Sampol
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D004730:Endothelium, Vascular / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D065427:Factor Xa Inhibitors; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000494:pharmacology; D015844:Heparin Cofactor II / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010426:Pentosan Sulfuric Polyester / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D010974:Platelet Aggregation / Q000187:drug effects; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control; D015912:Thrombolytic Therapy; D014779:Virus Replication / Q000187:drug effects
D000925:Anticoagulants; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D010426:Pentosan Sulfuric Polyester; D015844:Heparin Cofactor II; D006493:Heparin